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Abstract

Introduction

Colonization of urinary catheters by bacteria which
produce urease leads to an increase in urine pH, followed by deposition of the minerals struvite and hydroxyapatite. Adhesion of these encrusting deposits can be
reduced, but not prevented, by using catheters with a
smooth surface finish. Chemical methods for preventing
encrustation are not completely satisfactory. A better
way of preventing encrustation would be to prevent colonization of the catheter by bacteria. This might be
achieved by controlled release of antimicrobial agents
directly into the urine from the catheter itself. Preliminary experiments have demonstrated the feasibility of
controlled release from solid silicone. However, a simpler approach is diffusion of an antimicrobial agent from
a solution within the retention balloon of the catheter.
Further experiments are required to determine the concentrations required and whether they are achievable in
practice.

A mechanism has been proposed for the encrustation
of indwelling urinary catheters which involves their colonization by bacteria (Cox et al. , 1989a). This paper
reviews the evidence for the proposed mechanism and
considers its implications for the prevention of
encrustation.
Indwelling catheters are used to drain urine from the
bladder of patients who are suffering from urinary
incontinence or retention (Kunin, 1987). They consist
of a natural rubber latex, silicone rubber or PVC tube
which is inserted into the bladder. Most latex catheters
are coated with silicone elastomer, Teflon or hydrogel to
provide a smoother surface finish. The most common
design, the Foley catheter, is inserted through the urethra and is retained in the bladder by an inflatable balloon (Fig. 1). The tip allows the catheter to be inserted
(with the balloon deflated); the eye is a hole which allows urine to pass into the drainage lumen. The other
end of the catheter is connected to a drainage bag to provide a sealed system for the collection of urine. A second lumen (the inflation lumen) connects the inside of
the retention balloon to a side arm which terminates in
a one-way valve. When the catheter has been inserted,
water is injected, through this valve, to inflate the balloon and so retain the catheter in position.
Infection of the urinary tract is believed to be followed by colonization of the catheter surface by bacteria
(Kunin and Steele, 1985). Chemical changes then occur
in the urine which lead to the formation of encrusting
deposits (Bruce et al., 1974; Hedelin et al., 1991). In
principle, possible methods for preventing encrustation
are to prevent: (i) the adhesion of encrusting deposits to
the catheter surface, or (ii) chemical changes occurring
in the urine, or (iii) colonization of the catheter by bacteria. Methods (ii) and (iii) involve introducing a chemical agent to the inner surface of the catheter. Controlled
release allows the appropriate concentration to be delivered to the appropriate site, whilst relying on minimal
nursing care or patient compliance. The catheter itself
can provide a suitable vehicle for controlled release.

Key Words: Calcification, catheters, controlled release,
encrustation, infection.
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suggested that the calcium phosphate is present as brushite (CaHP04.2H2 0) (Hedelin et al., 1984) but X-ray diffraction, X-ray absorption spectroscopy and stoichiometric calculations based on the results of ion exchange .
chromatography indicate that it is poorly crystalline
hydroxyapatite (Holt et al., 1987; Hukins et al., 1989).
Hydroxyapatite (HAP) has the chemical formula
Ca5(P04)30H but is usually precipitated in an iinpure
form in biological systems.
Struvite occurs in urinary calculi when the urine is
infected by bacteria (e.g., Proteus) which produce the
enzyme urease (Griffith et al., 1976; Griffith and
Osborne, 1987). Urease catalyses the hydrolysis of urea
to produce carbon dioxide and ammonia. Figure 2
shows the chemical reactions which occur, leading eventually to the possible production of several different
ions. Since carbon dioxide is a weak acid (pKal = 6.4;
pK82 = 10.3), but ammonia is a relatively strong base
(pKb = 4.8), the urine becomes alkaline, i.e., its pH
increases. Above a pH value of 7 .2, struvite and HAP
are precipitated from urine (Elliot et al., 1958; Lindler
and Little, 1986).
It is has been proposed that this mechanism is
responsible for catheter encrustation (Cox et al., 1989a).
This proposal is consistent with the composition of the
encrusting deposits and the elevated pH of urine (up to
a value of 8) in catheterised patients (Hedelin et al.,
1991; Norberg et al., 1980). Catheter encrustation has
been mimicked in vitro by adding urease to artificial
urine (Hedelin et al., 1985b; Cox et al., 1988, 1989b).
Further evidence is provided by the appearance of bacteria in intimate association with the encrusting deposits
(Cox et al., 1989a; Stickler et al., 1993a). Furthermore, Proteus mirabilis has been identified as the organism most commonly isolated from encrusted catheters
(Stickler et al., 1993b). It has also been shown that
purified capsular polysaccharides from Proteus mirabilis
are capable of binding magnesium ions and enhancing
struvite formation (Domanski et al., 1994).
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Figure 1.

Schematic diagram of a Foley catheter
retained in the bladder by an inflated balloon.

urease

Figure 2. Chemical reactions which lead to an increase
in urine pH.
Mechanism of Encrustation

Adhesion of Deposits
The most common problem which accompanies urinary catheterization is the formation of encrusting deposits on the catheter surface (Getliffe and Mulhall, 1991;
Hedelin et al., 1985a; Kunin et al., 1987). These
deposits form a hard mass around the eye of the catheter
and can cause blockage of the drainage lumen. Analysis
of the deposits identified substantial concentrations of
ammonium, calcium, magnesium and phosphate ions
(Bruce et al., 1974; Hedelin et al., 1984; Holt et al.,
1987). The ammonium, magnesium and some of the
phosphate ions have been shown, by X-ray diffraction,
to be present in the form of the mineral struvite
(NH4MgP04.6H20) (Hukins et al., 1983). It has been

Prevention
In principle, adhesion of deposits could be prevented
by: (i) inhibiting crystallisation of mineral deposits, or
(ii) ensuring that there were no nucleation sites for crystal growth on the catheter surface. The second method
has the possible advantage that a surface finish with no
nucleation sites would be so smooth that it would be
expected to provide a poor surface for bacterial colonisation. Although both methods might be expected to
reduce encrustation, they have yet to be explored further, for the reasons given below.
184
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Inhibitors

the pH by acidifying the urine would prevent encrustation (Hedelin et al., 1991; Kunin, 1987). When acid
was added to a mixture of urease and artificial urine, its
pH dropped from a value of 8.5 to 6.5, as expected
(Bibby and Hukins, 1993). Unfortunately, the pH then
increased. The reason is that the pH of the system is
controlled by the equilibrium reactions shown in Figure
2. According to Le Chatelier8 principle, the equilibrium position shifts to oppose the imposed change, i.e.,
urease catalyses the conversion of more urea into ammonia and carbon dioxide so that the pH rises again. In
order to prevent the rise in pH, all the urea in the urine
would have to be converted into ammonia which would
then have to be neutralised by a suitable acid. This
approach would require an unreasonably large volume of
acid and so is not a feasible method for preventing
encrustation (Bibby and Hukins, 1993).

Controlled release of inhibitors or binding them to
the catheter surface might be expected to reduce encrustation. The possibility of preventing HAP deposition on
implanted heart valves by controlled release of diphosphonates from silicone rings has been described in the
literature (Levy et al., 1985). Substances, such as
diphosphonates, inhibit calcium phosphate crystallisation
by adsorbing on the surface of crystal surfaces and so
prevent further crystal growth (Blumenthal, 1989). Citrate is believed to inhibit HAP deposition in urine (Sutor
et al., 1978). Recent studies indicate that oral administration of citrates may significantly reduce crystallisation
in urine (Wang et al., 1994). These studies were published after the experimental feasibility studies reported
in this paper were completed and may indicate an alternate approach to preventing encrustation.
Unfortunately, substantial encrustation can still
occur in the presence of inhibitors. Albumin can be
shown to inhibit HAP deposition (Gilman and Hukins,
1994). However, albumin forms part of an in vitro
model system in which encrustation occurs (Cox et al.,
1988, 1989b).

Inhibition of urease
Urease can be inhibited by acetohydroxamic acid
(AHA) or hydroxyurea (Hamilton-Miller and Gargan,
1979; Carmignani et al., 1980). Only AHA has been
used as a pharmaceutical agent (to prevent formation of
urinary tract calculi as a result of infection); its recommended dosage is 250 mg, three to four times daily.
However, in vitro experiments suggest that a concentration of AHA of greater than 3.8 mg cm-3 is required
to prevent a rise in urine pH (Griffith et al., 1973).
Although AHA has been successfully used to reduce
catheter encrustation, patients suffered from side effects
which can include loss of appetite, mental depression,
nausea and vomiting (Burns and Gauthier, 1984). It
may be that the risk of side effects would not be so great
if AHA were delivered directly to the site of bacterial
colonization. However, the seriousness of these side
effects suggests that AHA is unlikely to be acceptable
for routine prevention of encrustation.

Surface finish
A smooth surface finish is expected to minimise
encrustation but it is unlikely that a sufficiently smooth
surface will be achieved to completely prevent its occurrence. Hydrogel-coated latex and all-silicone catheters
have the smoothest surfaces (Cox, 1987, 1990) but
encrusting deposits still adhere to them during in vitro
experiments (Cox et al., 1988, 1989b). Diamond-like
carbon provides a surface which is highly resistant to
adhesion of biological materials (Higson and Vadgama,
1993) and so might be reduce encrustation even further.
However, it is unlikely that a catheter could be manufactured and introduced into the body without any surface
scratches which could provide nucleation sites for crystallisation of encrusting deposits.

Removal of urease
In principle, the problem could be solved by digesting urease molecules with an proteolytic enzyme. Early
research on the action of proteolytic enzymes produced
ambiguous results (Sumner, 1951), perhaps because
pure, well characterised enzymes and substrates were
not then available. We have updated this research using
a selection of enzymes which are active at neutral or
alkaline pH values: trypsin, chymotrypsin, papain, ficin,
proteinase k and subtilisin Carlsberg.
All enzymes were obtained from Sigma Chemical
Company (St. Louis, Missouri, US). Ficin was a crude
preparation; all other proteolytic enzymes were crystallized and lyophilized by the supplier. Jack bean urease
was dissolved in 0.02 M sodium phosphate buffer (pH
7) which was adjusted to the optimum pH of the proteolytic enzyme being investigated by addition of sodium

Changes in Urine Chemistry
Principles
Changes which occur in the chemistry of urine, following colonization of the catheter surface by bacteria,
could be prevented in two ways: (i) by reversing the
increase in urine pH, or (ii) by preventing urease from
hydrolysing urea. There are two plausible methods for
achieving the second aim: to inhibit urease molecules or
to remove them from the system.

Changing urine pH
Since deposition of struvite and HA is a result of
elevated urine pH, it has been suggested that decreasing
185
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hydroxide. The concentration of the urease was 15
mg.cm-3 , corresponding to an activity of approximately
855 IU.cm-3 • Urease solution was incubated at 37°C
before adding protease and all digestions were performed at this temperature. The proteolytic enzyme was
added so its mass was 1130 times that of the urease.
This ratio of proteolytic enzyme/urease was chosen arbitrarily, although it ensured that the substrate (urease)
was present in excess. Although the same mass was
used for each of the six proteolytic enzymes, they may
have had different activities. However, the aim of this
experiment was to compare the effects of each enzyme
in its commercially available form. The activity of the
urease solution was determined before the addition of
proteolytic enzyme from the mean of four assays (Bibby
and Hukins, 1992). Two samples were removed from
the solution at time periods of 5, 15 and 25 minutes; the
urease activity at each time was determined as the mean
assay from the two samples. A control sample of the
original urease solution was incubated at 3rC with no
enzyme and the activity determined after a period of 30
minutes (mean of two assays). Digestion experiments
were repeated four times for enzymes which were found
to reduce urease activity to less than 80% of its initial
value.
Three proteolytic enzymes (subtilisin Carlsberg,
chymotrypsin and proteinase k) reduced urease activity
to less than the 80% level in the time period of the
experiment. Proteinase k was the only enzyme which
reduced the activity to less than 60%; its results are
shown in Figure 3a. For both subtilisin Carlsberg and
chymotrypsin, the reduction was to not less than the
70% level. These results are consistent with proteinase
k being especially active towards native enzymes and
suggests that it could prove useful in removing urease.
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Figure 3. Effect of proteinase k on the activity of
urease in solution. In (a) the proteinase k was also in
solution, in (b) it was immobilised. Further details are
given in the text.

Application of immobilised proteinase k
There are two reasons for using proteinase k in an
immobilised form: (i) to prevent it being flushed from
the catheter, and (ii) to prevent it digesting itself. Loss
of proteolytic enzyme would lead to depletion of supply;
compensating for this loss with excess enzyme could
prove an expensive solution to the problem. Enzymes
are commonly immobilised on to hydrogels, so there
should be no problem in immobilising proteinase k on to
the surface of the drainage lumen of a hydrogel-coated
catheter. Therefore, the experiments described in the
previous section were repeated with immobilised
proteinase k.
Proteinase k immobilised on agarose was purchased
from Sigma Chemical Company. Its activity was comparable to that of the free enzyme. However, in this
experiment, the ratio of proteolytic enzyme to urease
was 1/60, by mass. The mixture was incubated for 15

minutes at 37°C and the immobilised enzyme was then
removed by centrifugation for 5 minutes. A control
contained no proteolytic enzyme and was incubated for
25 minutes. Four experiments were performed.
Figure 3b shows that the immobilised enzyme
caused an even greater and more rapid digestion of
urease than the free enzyme. However, a problem still
remains in preventing catheter encrustation by immobilising proteinase k on the surface of the drainage lumen.
Urease is present in the urine of patients infected with
the bacteria which produce it, as a result of cell lysis
(Griffith and Osborne, 1987). It has been suggested that
this extracellular urease is important in the formation of
kidney stones (Griffith and Osborne, 1987). However,
the pH of the urine surrounding bacteria which produce
urease can rise without cell lysis, i.e., intracellular
urease may also be important (Griffith et al., 1973).
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of urinary catheters
1972; Kunin, 1987). Rigorous cleansing routines reduce
periurethral infection (Brehmer and Marsden, 1972) and
closed drainage systems minimise intraluminal infection
(Gillespie et al., 1967; Kunin, 1987); however, once
infection is introduced into the system, closed drainage
serves no purpose. Application of bladder washout solutions also breaks closed drainage systems (Kirk et al.,
1979; Warren et al., 1978). If intraluminal infection is
prevented, infection still proceeds by the periurethral
route (Gillespie et al., 1983).
The antimicrobial properties of silver (Foye, 1977)
have been exploited in two ways. A randomized clinical
trial of catheters coated with silver showed a statistically
significant decrease in the incidence of bacteriuria after
6 days (Liedberg and Lundeberg, 1990). Such a catheter may have a short-term effect in minimising encrustation, but the long-term effects are unknown. A plug
which contains silver has been introduced for attaching
the catheter to the drainage bag (Silverline, Clinimed,
High Wycombe, U.K.). This antimicrobial layer may
prevent migration of bacteria from the drainage bag into
the catheter but does not address the problem of periurethral infection.
An alternative approach to preventing infection and,
hence, encrustation, is the prophylactic application of
antimicrobial agents. Controlled release of these agents
has several advantages: (i) application of the agents to
the site of infection, (ii) avoidance of breaking a closed
drainage system, (iii) reduction in nursing care, and (iv)
use of the catheter as a means of introducing the agent.
A possible problem with this approach is that the routine
use of antimicrobial agents may give rise to resistant
strains (Britt et al., 1977; Butler and Kunin, 1968a;
Dudley and Barriere, 1981). However, this is likely to
be more of a problem with bladder washout solutions
where the agent must be applied intermittently. It has
been found that catheters impregnated with antimicrobial
agents lose their activity within 48 hours (Butler and
Kunin, 1968b). More recent work on release from linings of the walls of catheters provides little detail
(Huajin, 1988; Mochizuki et al., 1985). An alternative
approach involves ionically bonding antimicrobial agents
to the catheter wall; molecules are released as the bonds
break (Sakamoto et al., 1985).
Here the construction of the catheter is exploited as
a means of releasing antimicrobial agents into the urine.
One approach involves impregnating silicone with the
agent. This is achieved by mixing liquid silicone with
the agent; the mixture subsequently cures so that the
agent is incorporated into solid silicone. The silicone
could be introduced as a plug within the tip of the catheter (Fig. 4a) or as a lining in the drainage lumen (Fig.
4b). The other approach exploits the catheter balloon as
a reservoir for a solution of antimicrobial agent which

1---T-I- - coating impregnated

J

with beneficial
substances

a

plug

b

figure 4. Incorporation of a controlled release matrix
a> (a) a lining and (b) a plug near the eye of the
Cltheter.

Thus, extensive studies of the relative importance of
i!ltracellular and extracellular urease would be needed
~fore this approach was proved to be of value.

Prevention of Bacterial Colonization
Eackground
Since improving the surface flnish of a catheter is
uolikely to prevent encrustation and the chemical methods described above all present problems, it appears reascmable to solve the problem at its source, i.e., to prevent the colonization of the catheter by bacteria. Prevention of infection would prevent encrustation. Infection of the urine in a catheter is already perceived as a
problem, albeit separate from that of encrustation, in the
c3theterized patient (Kunin and Steele, 1985; Slade and
Gillespie, 1985). It is believed to occur by two different
routes: (i) through the drainage system (intraluminally),
a11d (ii) between the outer surface of the catheter and the
ufethral mucosa (periurethrally) (Brehmer and Marsden,
187
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Table 1. Compositions of the samples used for controlled release experiments.

could then diffuse through the wall of the balloon into
the residual urine in the bladder and then pass through
the drainage lumen.
Preliminary experiments were performed with chlorhexidine (in solid silicone plugs) and mandelic acid (in
solution, filling the retention balloon of all-silicone catheters). Mandelic acid has the advantage that it is effective against Proteus in the biofilms which coat the drainage lumen of encrusting catheters (Stickler and Hewett,
1991; Stickler et al., 1991). These biofilms consist of
a mixture of bacteria, macromolecules and minerals; the
bacteria are protected from antibiotics by the barrier
provided by their environment (Cox et al., 1989a; Nickel et al., 1985; Ramsay et al., 1989). A further advantage of mandelic acid is that it does not give rise to
resistant strains (Robertson and Norton, 1990). However, Proteus mirabilis, which was the commonest species colonizing a sample of encrusted catheters (Stickler
et al., 1993a,b), is especially sensitive to trimethoprim,
cefuroxime, nalidixic acid and norfloxacin (Garrod et
al., 1981); it would, therefore, be worth investigating
controlled release of these antibiotics from catheters in
future experiments.

Silicone1

Chlorhexidine2

NaC13

MDX4
MDX4
MDX4

33%
40%
30%

0%
0%
15%

Provil L
Provil L
Provil L

20%
30%
20%

0%
0%
15%

Q7
Q7
Q7

30%
40%
30%

0%
0%
15%

1Dow

Corning silicone elastomer (MDX4-4210), Provil
L dental silicbne or Dow Corning silicone gel (Q7
2218).
2Expressed as the percentage of the total mass of the
specimen consisting of chlorhexidine diacetate.
3Expressed as the percentage of the total mass of the
specimen consisting of NaCl.

Chlorhexidine release from silicone
Chlorhexidine has been claimed to reduce infection
on latex catheters (Zinsser et al., 1968). However,
some species of Proteus are not very susceptible. The
controlled release of chlorhexidine diacetate from ethyl
cellulose, hydrogels, latex and biodegradable protein
have been investigated (Friedman and Golomb, 1982;
Mirth et al., 1989; Mochizuki et al., 1985; Steinberg et
al., 1990). Most of the devices have been developed for
dental applications. Factors which affect the rate of release of chlorhexidine include: (i) the mass of chlorhexidine incorporated, (ii) the surface area, and (iii) the permeability of the matrix (Friedman and Golomb, 1982;
Mirth et al., 1989; Mochizuki et al., 1985; Steinberg et
al., 1990). Permeability of silicone matrices for the release of diphosphonates has been increased by adding
polyethylene glycol (PEG); the PEG is then dissolved
out in acetone, leaving pores in the matrix (Golomb et
al., 1987). However, we found that chlorhexidine prevents silicone from curing in the presence of PEG. In
our experiments, attempts were made to increase the porosity of the matrix by adding sodium chloride. The sodium chloride was expected to dissolve in water, introducing pores into the matrix. Experiments were performed with three formulations of silicone: (i) Dow
Corning silicone elastomer (MDX4-4210; Dow Corning
Corp., Medical Products, Midland, Michigan, USA),
(ii) Provil L dental silicone (Bayer Dental, Leverkusen,
Germany), and (iii) Dow Corning silicone gel (Q7
2218). All three silicones are prepared by mixing tWo

components; in each case, incorporation of chlorhexidine
diacetate produced a stronger, more rigid solid. The
experiments tested release from one side of discs of
material, to simulate release from the surface lining of
a catheter.
Table 1 lists the compositions of the specimens
used. The particle size of the chlorhexidine diacetate
was determined by image analysis; 97% of the area
occupied by 1250 particles consisted of particles whose
area was less than 24 p.m2 • For the sodium chloride
added to some specimens, the corresponding particle
area was less than 80 p.m2 • All samples were thoroughly mixed and cast as sheets; air bubbles were removed
by placing the mixtures in a vacuum for 15 minutes.
Since Dow Corning Q7 takes at least 24 hours to cure at
room temperature, these samples were rotated at 0.7
rad.s- 1 to prevent settling of chlorhexidine diacetate.
Samples were tested as discs of area 1. 77 cm2 which
were backed with an impermeable coating to ensure that
release was restricted to a single face.
Each disc was placed in a fixed volume of distilled
water in a conical flask that had been treated with Sigmacote (Sigma, St. Louis, MO), because chlorhexidine
is believed to be affected by glass (E. Chan tier, personal
communication). For each of the formulations listed in
Table 1, six discs were tested . Other flasks contained
solutions of chlorhexidine to monitor its stability during
the course of each experiment. Samples were removed
periodically and the concentration of chlorhexidine
188
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Figure S. Cumulative mass of chlorhexidine diacetate
released from silicone gel Q7 for specimens containing
30% (circles) and 40% (squares) loadings (Table 1).
Error bars represent one standard deviation.

Figure 6.

Apparatus used to investigate release of
mandelic acid from an inflated retention balloon.

diacetate monitored by ultraviolet absorbance at a wavelength of 276 nm.
Chlorhexidine diacetate was released from all the
formulations listed in Table 1 but Dow Corning Q7 was
shown to be the most suitable matrix for this application.
The release from MDX4 was comparatively slow (cumulative mass released was about 2 mg in 300 hours for a
40% loading) when compared with Q7 (over 5 mg in
300 hours for 40% loading) and Provil L (about 5 mg in
300 hours for 30% loading). · However, Provil L
showed an initial rapid release, while that from Q7 was
highly linear (r = 0.99), as shown in Figure 5. Furthermore, it was found possible to achieve a higher
loading of chlorhexidine diacetate in Q7 (40%) than in
Provil L (30% ). All experiments on samples containing
sodium chloride were discontinued because of their rapid
physical deterioration.
The concentration of chlorhexidine released into the
urine of a catheterised patient can be estimated. From
the slope of Figure 5 (0.0204 ± 0.0008 mg.h- 1), the
concentration of chlorhexidine in the urine of an elderly
patient passinJ typically 800 cm3 per day would be
0.006 mg.cm- . Although this is less than in bladder
washout solutions (0.2 mg.cm-3), it is possible that
lower concentrations would be effective in continuous
application.

screw adapter into one of the side necks of a triplenecked flask (250 cm3 capacity), as shown in Figure 6.
Distilled water (125 cm3) was added to the flask and circulated through the drainage lumen of the catheter by
means of a peristaltic pump. (A limited number of
experiments using artificial urine yielded closely similar
results.) The balloon was inflated with mandelic acid
solution (30 cm3). Concentrations of 0.025, 0.050,
0.075, 0.100 and 0.125 g.cm-3 were used. Six catheters
were used for each concentration studied. Samples
(0.08-0.5 cm3) of the circulating water were removed
periodieally through the central neck of the flask. The
mandelic acid concentration was monitored by ultraviolet
absorption at a wavelength of 256 nm. Sink conditions
were maintained throughout by changing the circulating
liquid every time the mandelic acid concentration
exceeded 0.016 g.cm-3 • (This ensured that the release
of the mandelic acid from the balloon was not inhibited
by its concentration in the surrounding liquid. Thus, the
experiments mimicked release into the drainage lumen of
a catheter where the substance released would be flushed
into the collecting bag.) Six different catheters were
used for each mandelic acid concentration investigated.
Figure 7 shows that mandelic acid diffuses through
the catheter balloon; Figure 7a compares the results for
all five concentrations used. The results for the most
concentrated mandelic acid solutions are incomplete
because the balloons persistently ruptured. However, a
separate series of experiments showed no decrease in
balloon strength, as measured by bursting pressure, after
exposure to mandelic acid solution. In Figure 7b, the
results for all concentrations are shown to lie on a single

Mandelic acid release from the balloon
The experiments described in this section show that
mandelic acid can diffuse through the retention balloon
of an all-silicone catheter. Thus, the catheter itself can
be used as the vehicle for controlled release. The advantages of using mandelic acid for controlling catheter
infection have been described above.
An all-silicone Foley catheter (size 16 or 18; Bard
Ltd., Clacton-on-Sea, U.K.) was introduced through a
189
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3000 . -------------------------.

smooth curve when the cumulative mass of mandelic
acid released is expressed as a percentage, P, of the
initial mass in the balloon. This curve can be represented by the second-order polynomial of the form:

-e2ooo

P = at- btl

;1500

2500

(1)

~

ca

when t is the time in hours, a = 0.207 ± 0.005
b = (1.32 ± 0.08) x 104 h-2 . In a short time interval,
l:lr, after a time interval, r, has elapsed, the mass, m, of
mandelic acid released is then given approximately by:

=

(fDo/100)(a - 2hT)I:lr

• •

E1000

h- 1 and

m

....

500

0 .,.-t · .

0

a

(2)

where 111o is the initial mass of mandelic acid in the balloon.
It is clear, from the results of Figure 7, that mandelic acid was still being released after a period of over
4 weeks. Eq. 2 shows that between days 10 and 11, the
mass of mandelic acid diffusing through the balloon was
0.104 g for a filling solution with a concentration of 0.1
g.cm-3 . For an elderly person expressing an average of
800 cm3 of urine per day, this corresponds to a mandelic
acid concentration of 0. 13 mg.cm-3 . Mandelic acid is
bactericidal in urine at a concentration of 5 mg.cm-3
(Rosenheim, 1935). Further research needs to be performed to determine: (i) the minimum concentration at
which it would be effective for preventing encrustation,
(ii) methods for increasing the diffusion rate, and (iii)
methods for increasing the concentration of mandelic
acid in the balloon. Also, there are many other potentially useful antimicrobial agents whose diffusion properties have yet to be investigated. Release through a
membrane can also be achieved when drugs are encapsulated into micelles or reversed micelles (Juni et al.,
1978).
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Figure 7. (a) Cumulative mass of mandelic acid
released from a silicone retention balloon filled with
solutions of concentration: 0.125 (diamonds), 0.100
(large squares), 0.075 (triangles), 0.050 (crosses) and
0.025 (small squares) g.cm-3 . (b) When the results for
all concentrations are expressed as a percentage of the
mass of mandelic acid available for release, they lie on
the same smooth curve.

Conclusions
There do not appear to be any satisfactory chemical
methods for preventing catheter encrustation. Although
acidic bladder washout solutions may be helpful for
removing encrusting deposits, once they have formed
(Getliffe, 1994), acidification of the urine cannot prevent
encrustation (Bibby and Hukins, 1993). The reason is
that the effect of adding acid is rapidly reversed by the
enzyme urease, produced by the bacteria which colonize
the catheter surface. It is the reactions which are catalysed by urease (Fig. 2) which are responsible for encrustation in the first place. Urease inhibitors which are
presently available have side effects that make them unsuitable for routine administration (Burns and Gauthier,
1984). However, if a safe and effective urease inhibitor
could be developed, it might have considerable potential
for preventing encrustation. Proteolytic enzymes, especially proteinase k, can digest urease. Although there is

extracellular urease in infected urine, as a result of
bacterial cell lysis, intracellular urease may also be
important (Griffith et al., 1973). Enzymes could be
immobilised on the catheter surface to digest the
extracellular urease, but it is difficult to devise a method
to digest intracellular urease. One possibility is to also
immobilise an enzyme which digests bacterial cell walls
to the catheter surface. However, this possibility has
not been seriously investigated.
Smooth catheter surfaces are less likely to be
encrusted than rough surfaces. However, some encrustation occurs on the smoothest surfaces currently available (Cox et al., 1988, 1989b). Thus, smooth surfaces,
e.g., those of all-silicone or hydrogel-coated latex catheters, are beneficial but cannot prevent encrustation
completely.
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The most promising approach to preventing encrustation is to prevent the catheter from being colonized by
the bacteria which are ultimately responsible for the
problem. Controlled release of antimicrobial agents
would ensure that they targeted the site of infection and
is expected to be more effective than intermittent application. In any case, application of antibiotic bladder
washout solutions breaks the closed drainage system,
and so, could lead to renewed infection (Kirk et al.,
1979; Warren et al., 1978). Preliminary experiments
show that controlled release is feasible. However, it has
yet to be determined whether it can deliver concentrations of antimicrobial agents which are sufficiently high
to prevent encrustation.
Using the retention balloon of the catheter as the
reservoir for controlled release has the advantage that no
change in the design of the conventional Foley catheter
is required. In a patient, the release of antimicrobial
agent in the urine could be monitored by periodically
determining the concentration remaining in the solution
filling the balloon. If it had fallen to an unacceptably
low level, it could be replenished without disturbing the
catheter. However, further experiments need to be performed to develop suitable solutions.
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sition of proteins from body fluids on the catheter surface where they then mask the specially applied coating.
What are your views on this?
R.J.C. McLean: Throughout this paper, considerable
attention is given to the properties of catheter surfaces
and their influence on bacterial and crystal adhesion.
One must consider that in a dirty system such as the urinary tract, any surface will encounter urine components
and may, thus, acquire a conditioning film of macromolecules (Reid et al., 1992). Such a film will mask
the underlying surface and interfere with any crystalpreventing properties that it has.
Authors: This problem is likely to occur when films of
proteins, polysaccharides or other organic deposits are
formed on the catheter. Ideally, one would wish to develop a surface coating with a sufficiently low surface
energy to inhibit the adhesion of these deposits. Thus,
we are concerned to minimize the adhesion of all foreign
substances, including macromolecules as well as inorganic crystals and bacteria. Note also that a smooth
surface coating on the catheter will cover inhomogeneities in the bulk material which might otherwise act
as nucleation sites for crystallization of struvite or
hydroxyapatite.
K.A. Getliffe: There is some evidence, from animal
studies, that acidic solutions disrupt the mucus layer
lining the bladder mucosa. Would continuous slow release of mandelic acid from the catheter balloon present
an unacceptable risk of damage to the bladder tissue?
Authors: The answer to this question depends on how
the pH of the urine affects disruption of the mucus layer
and would have to be answered experimentally. However, there are two important points to note. One is that
infected urine may have an abnormally high pH value so
that acidification would not then be expected to have an
adverse effect. The problem of damage by acidification
could then be overcome by filling the balloon with an
acid solution only when the urine showed signs of elevated pH. The other point is that intermittent acidification with bladder wash-out solutions is likely to lead to
much lower pH values, if it is to be effective in removing encrusting deposits, than those arising from gradual
controlled release of mandelic acid.
D.J. Stickler: There are reports in the literature of the
poor activity of chlorhexidine against Proteus mirabilis
in urine (e.g. , Stickler et al., 1987). Dance et al.
(1987) also reported a large outbreak of urinary tract
infections by a chlorhexidine resistant strain of Proteus
mirabilis in catheterized patients in a hospital where the
catheter care policy involved the extensive use of chlorhexidine. It seems to me that the release of this antiseptic from catheters, as suggested by the authors, could

Discussion with Reviewers
K.A. Getliffe: Urinary catheters have been manufactured with a range of coatings designed to combat catheter-associated infection and/or encrustation. Where success has been demonstrated, it tends to be in the shortterm only. It seems likely that this may be due to depo193
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experiment.

be counter productive and select for precisely the species
that produces the problem of encrustation. Would the
authors please comment on this possibility?
Authors: Chlorbexidine was chosen to test the feasibility of controlled release of an antimicrobial agent from
a catheter. The reason for this choice was that it bas
been claimed to reduce infection on catheters, is a component of some bladder wash-out solutions and can be
released from a range of solid matrices, as described in
the text. However, we did not wish to imply that it was
the most suitable antimicrobial agent for preventing
infection by Proteus mirabilis. Resistance and related
problems are important considerations, as we outlined in
the main text. The references cited by the reviewer
imply that an alternative agent should be used in further
studies of controlled release.

R.J.C. McLean: It bas been our experience that catheter surfaces become colonized quite rapidly by biofilmforming bacteria. Any adhesion of a microorganism or
its surface region, e.g., capsule, will alter and influence
catheter chemistry. When growing as biofilms, bacteria
can create microenvironments in their immediate vicinity
which can be chemically quite different from the bulk
urine environment (McLean et al., 1991). In addition,
surface polymers of bacteria can also influence struvite
crystal growth (Clapham et al., 1990; Dumanski et al.,
1994). While catheter chemistry is important in controlling mineralization, it needs to be addressed in context
with other chemical and biological features.
Authors: This supports our conclusion that the most
promising approach to preventing encrustation is to prevent the catheter from being colonized by the bacteria
which are ultimately responsible for the problem.

D.J. Stickler: How does mandelic acid pass from the
catheter balloon into the urine? Could the authors comment on the nature of the chemical agents that are likely
to be able to diffuse in this way?
Authors: We believe that the mechanism is diffusion
through the material of the balloon. Therefore, we
would expect that the diffusion rate would be greater for
low molecular weight compounds with hydrophobic
groups which would improve their miscibility with the
balloon material. Oil soluble dyes, such as Sudan IV,
can diffuse through a silicone membrane whilst methylene blue, a water soluble dye, cannot (Chien, 1980).
Preliminary studies on diffusion through catheter balloons showed that molecular weight (in the range 36898) did not limit the ability of a substance to diffuse,
although it may have influenced the rate of diffusion
(Bibby, 1992). The most important factor was whether
the substance had some hydrophobic nature. For example, oil red 0, a large hydrophobic molecule (molecular
weight, 408), was found to diffuse through the membrane, while hydrochloric acid did not.

R.J.C. McLean: Do the authors have any information
on the physical structure of the catheter surface as it
directly pertains to nucleation of struvite and/or hydroxyapatite (i.e., do different catheter materials promote or
inhibit mineral growth)?
Authors: We are not aware of any materials suitable
for coating the surface of catheters which inhibit growth
of mineral crystals. However, a smooth surface is less
likely to provide nucleation sites for crystallization than
a rougher surface. Scanning electron micrographs of
silicone catheters encrusted in vitro show struvite crystallizing at the intersection of surface ripples with
hydroxyapatite deposits between the crystals of struvite
(Cox, 1988). However, during an in vitro test lasting
for 11 weeks, there was no significant difference between the mass of mineral deposited on hydrogel-coated
latex, latex coated with silicone elastomer and all-silicone catheters (Cox et al., 1989b).

D.J. Stickler: What concentrations of mandelic acid
were achieved in the bladder when artificial urine was
used as an alternative to distilled water? Have you used
human urine in these experiments?
Authors: Substituting artificial urine for distilled water
made no appreciable difference to the results presented
in Figure 7a. It is important to note that these results
cannot be directly related to mandelic acid concentration
in the bladder because experiments were performed under sink conditions, i.e., the liquid was changed whenever the mandelic acid concentration exceeded a value of
0.016 g.cm-3 . The reasons for this experimental design
are given in the text. We have not used human urine
because its composition is not constant, and, therefore,
its use introduces a hidden variable into the design of the

R.J.C. McLean: The data pertaining to the kinetics of
antibiotic release from catheters is interesting. Have the
authors tested any of these?
Authors: We have not tested any of these ideas on systems containing bacteria. Optimizing the system being
used could well prove to be an important part of any
such testing programme.
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